SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-014881
Filing Date
2021-01-22
Accepted
2021-01-22 17:06:02
Documents
18
Period of Report
2021-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d845914d8k.htm   iXBRL 8-K 30604
2 EX-1.1 d845914dex11.htm EX-1.1 235131
3 EX-5.1 d845914dex51.htm EX-5.1 8476
4 EX-99.1 d845914dex991.htm EX-99.1 11192
5 EX-99.2 d845914dex992.htm EX-99.2 11541
9 GRAPHIC g845914g0122030924604.jpg GRAPHIC 2605
10 GRAPHIC g845914g0122031154877.jpg GRAPHIC 3155
  Complete submission text file 0001193125-21-014881.txt   508198

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tcrr-20210119.xsd EX-101.SCH 3058
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrr-20210119_lab.xml EX-101.LAB 18888
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrr-20210119_pre.xml EX-101.PRE 11852
11 EXTRACTED XBRL INSTANCE DOCUMENT d845914d8k_htm.xml XML 3464
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38811 | Film No.: 21546957
SIC: 2836 Biological Products, (No Diagnostic Substances)